Trade WVE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Wave Life Sciences, Inc. (WVE) is trading at US$4.86, up 3.40% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$1.04B. Over the past 52 weeks, WVE has traded between US$4.65 and US$21.73. On Syfe you can trade WVE with $0 commission and add it to your watchlist.
| Previous close | US$4.70 |
|---|---|
| Market cap | US$1.04B |
| 52-week range | US$4.65 – US$21.73 |
| Volume | 3.03M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Wave Life Sciences, Inc.
Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.
Year: 2015
B. Riley Adjusts Wave Life Sciences Price Target to $22 From $31, Maintains Buy Rating
Jul 31, 1:39 PM · MT Newswires
--Wedbush Adjusts Wave Life Sciences Price Target to $12 From $15, Maintains Outperform Rating
Jul 30, 4:22 PM · MT Newswires
Wave Life Sciences Shares Fall After Wider Q2 Net Loss, Lower Revenue
Jul 30, 2:09 PM · MT Newswires
-- Earnings Flash (WVE) Wave Life Sciences Ltd. Reports Q2 Revenue $2.3M, vs. FactSet Est of $7.4M
Jul 30, 11:31 AM · MT Newswires
Wave Life Sciences, Inc. (WVE) stock is trading at US$4.86, +3.40% from the previous close of US$4.70.
The market cap for Wave Life Sciences, Inc. (WVE) stock is approximately US$1.04B.
The 52-week high for Wave Life Sciences, Inc. (WVE) stock is US$21.73.
The 52-week low for Wave Life Sciences, Inc. (WVE) stock is US$4.65.
Wave Life Sciences, Inc. (WVE) does not currently pay a dividend.
Stay on top of WVE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
